Recent Posts

Blog, Patient Advocacy, epilepsy, RareDiseases, Chapter 8
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Posted 21st May 2021

Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust

Read More
Patient Advocacy , Chapter 8 , Chapter 7 , Chapter 1 , Chapter 2
The complexity of epilepsy - an overview
Posted 1st December 2020

The complexity of epilepsy - an overview

Read More
Patient Advocacy , Chapter 8
The future of genomic medicine: can it fulfil its promises?
Posted 20th September 2020

The future of genomic medicine: can it fulfil its promises?

Read More
1
Blog , Patient Advocacy , epilepsy , RareDiseases , Chapter 8
Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust
Posted 21st May 2021

Dr Charles Steward joins as “friend” of the UK Infantile Spasms Trust

Read More
Patient Advocacy , Chapter 8 , Chapter 7 , Chapter 1 , Chapter 2
The complexity of epilepsy - an overview
Posted December Dec 1st 2020

The complexity of epilepsy - an overview

Read More
Patient Advocacy , Chapter 8
The future of genomic medicine: can it fulfil its promises?
Posted September Sep 20th 2020

The future of genomic medicine: can it fulfil its promises?

Read More
1
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.